![Photodynamic Therapy With Motexafin Lutetium Induces Redox-Sensitive Apoptosis of Vascular Cells | Arteriosclerosis, Thrombosis, and Vascular Biology Photodynamic Therapy With Motexafin Lutetium Induces Redox-Sensitive Apoptosis of Vascular Cells | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/6633b5ed-1633-4310-b728-727d03987a44/hq0411636001.jpeg)
Photodynamic Therapy With Motexafin Lutetium Induces Redox-Sensitive Apoptosis of Vascular Cells | Arteriosclerosis, Thrombosis, and Vascular Biology
![Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer | Science Translational Medicine Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abb3738/asset/34a3b207-a551-4c18-94ed-7d171e1395b2/assets/images/large/scitranslmed.abb3738-f2.jpg)
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer | Science Translational Medicine
![Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer | Science Translational Medicine Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abb3738/asset/29c8b59a-b236-4e73-8f16-716141971a13/assets/images/large/scitranslmed.abb3738-f3.jpg)
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer | Science Translational Medicine
![Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer | Science Translational Medicine Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abb3738/asset/1fef0e8d-d64f-4bcf-8f27-c4ff4bbe0865/assets/images/large/scitranslmed.abb3738-f1.jpg)
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer | Science Translational Medicine
![Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer | Science Translational Medicine Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abb3738/asset/c7fa0287-6746-4163-8330-961677732bfc/assets/images/large/scitranslmed.abb3738-f5.jpg)
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer | Science Translational Medicine
Description of Marylynnia puncticaudata n. sp. (Nematoda, Cyatholaimidae) from Bizerte Lagoon, Tunisia F. Boufahja & H. Beyr
![Column Characterization and Selection Systems in Reversed-Phase High-Performance Liquid Chromatography | Chemical Reviews Column Characterization and Selection Systems in Reversed-Phase High-Performance Liquid Chromatography | Chemical Reviews](https://pubs.acs.org/cms/10.1021/acs.chemrev.8b00246/asset/images/medium/cr-2018-00246v_0023.gif)